- Home
- CCEL vs FOSL Comparison
CCEL vs FOSL Comparison
Compare CCEL & FOSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEL
- FOSL
- Stock Information
- Founded
- CCEL 1989
- FOSL 1984
- Country
- CCEL United States
- FOSL United States
- Employees
- CCEL N/A
- FOSL N/A
- Industry
- CCEL Managed Health Care
- FOSL Consumer Specialties
- Sector
- CCEL Health Care
- FOSL Consumer Discretionary
- Exchange
- CCEL Nasdaq
- FOSL Nasdaq
- Market Cap
- CCEL 50.0M
- FOSL 112.2M
- IPO Year
- CCEL 1997
- FOSL 1993
- Fundamental
- Price
- CCEL $7.79
- FOSL $1.85
- Analyst Decision
- CCEL
- FOSL
- Analyst Count
- CCEL 0
- FOSL 0
- Target Price
- CCEL N/A
- FOSL N/A
- AVG Volume (30 Days)
- CCEL 12.4K
- FOSL 2.2M
- Earning Date
- CCEL 12-31-2024
- FOSL 11-07-2024
- Dividend Yield
- CCEL 3.17%
- FOSL N/A
- EPS Growth
- CCEL N/A
- FOSL N/A
- EPS
- CCEL N/A
- FOSL N/A
- Revenue
- CCEL $31,838,476.00
- FOSL $1,223,954,000.00
- Revenue This Year
- CCEL $3.97
- FOSL N/A
- Revenue Next Year
- CCEL $0.91
- FOSL N/A
- P/E Ratio
- CCEL N/A
- FOSL N/A
- Revenue Growth
- CCEL 1.95
- FOSL N/A
- 52 Week Low
- CCEL $4.47
- FOSL $0.75
- 52 Week High
- CCEL $9.50
- FOSL $2.61
- Technical
- Relative Strength Index (RSI)
- CCEL 43.85
- FOSL 55.78
- Support Level
- CCEL $7.60
- FOSL $1.64
- Resistance Level
- CCEL $9.10
- FOSL $2.01
- Average True Range (ATR)
- CCEL 0.25
- FOSL 0.19
- MACD
- CCEL -0.14
- FOSL -0.03
- Stochastic Oscillator
- CCEL 15.08
- FOSL 31.82
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.
About FOSL Fossil Group Inc.
Fossil Group Inc is a design, innovation and distribution company in consumer fashion accessories. The products include traditional watches, smartwatches, jewelry, handbags, small leather goods, belts and sunglasses. The reportable segments are comprised of 1) Americas segment includes sales in Canada, Latin America and the United States. 2) Europe segment includes sales in European countries, the Middle East and Africa. 3) Asia segment includes sales in Australia, China, India, Indonesia, Japan, Malaysia, New Zealand, Singapore, South Korea and Thailand. Each reportable operating segment includes sales to wholesale and distributor customers, and sales through Company-owned retail stores and e-commerce activities based on the location of the selling entity.